BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

747 related articles for article (PubMed ID: 16036293)

  • 1. Pelvic abscess in intrauterine device users.
    Tanir HM; Hassa H; Ozalp S; Kaya M; Oge T
    Eur J Contracept Reprod Health Care; 2005 Mar; 10(1):15-8. PubMed ID: 16036293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pelvic actinomycosis associated with use of intrauterine device: a new challenge for the surgeon.
    Doberneck RC
    Am Surg; 1982 Jan; 48(1):25-7. PubMed ID: 7065552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pelvic actinomycosis in Tunisia: five cases].
    Chelli D; Hassini A; Aloui F; Sfar E; Zouaoui B; Chelli H; Chanoufi B
    Sante; 2008; 18(2):77-82. PubMed ID: 19188130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of ovarian actinomycosis.
    Iwasaki M; Nishikawa A; Akutagawa N; Fujimoto T; Teramoto M; Kudo R
    Infect Dis Obstet Gynecol; 2003; 11(3):171-3. PubMed ID: 15022879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Older" age is a risk factor for pelvic inflammatory disease in intrauterine device users.
    Viberga I; Odlind V; Berglund L
    Acta Obstet Gynecol Scand; 2005 Dec; 84(12):1202-7. PubMed ID: 16305709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extent of surgery for pelvic inflammatory disease in relation to duration of intrauterine device use.
    Stadel BV; Schlesselman S
    Obstet Gynecol; 1984 Feb; 63(2):171-8. PubMed ID: 6694810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tubo-ovarian abscess. An analysis of 20 cases].
    Varela R; Gonçalves V; Telhado C; Hormigo C; Tavares C
    Acta Med Port; 1995 Oct; 8(10):537-42. PubMed ID: 8533614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pelvic actinomycosis: just think of it].
    Marret H; Wagner N; Ouldamer L; Jacquet A; Body G
    Gynecol Obstet Fertil; 2010 May; 38(5):307-12. PubMed ID: 20430667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unilateral tubo-ovarian abscess and intrauterine contraceptive devices.
    Dawood MY; Birnbaum SJ
    Obstet Gynecol; 1975 Oct; 46(4):429-32. PubMed ID: 1165878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged use of intrauterine contraceptive device as a risk factor for tubo-ovarian abscess.
    Charonis G; Larsson PG
    Acta Obstet Gynecol Scand; 2009; 88(6):680-4. PubMed ID: 19412803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abdominal manifestations of actinomycosis in IUD users.
    Asuncion CM; Cinti DC; Hawkins HB
    J Clin Gastroenterol; 1984 Aug; 6(4):343-8. PubMed ID: 6481117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The intrauterine device in the present and future.
    Rivera R; Chi IC; Farr G
    Curr Opin Obstet Gynecol; 1993 Dec; 5(6):829-32. PubMed ID: 8286697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuboovarian abscess caused by Candida in a woman with an intrauterine device.
    Hsu WC; Lee YH; Chang DY
    Gynecol Obstet Invest; 2007; 64(1):14-6. PubMed ID: 17192715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical analysis of pelvic abscess with endometriosis].
    Liu YT; Shi HH; Yu X; Wang S; Fan QB; Liu HY
    Zhonghua Fu Chan Ke Za Zhi; 2017 Mar; 52(3):164-167. PubMed ID: 28355687
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pelvic inflammatory disease and an abscessed endometriosis cyst: a diagnostic problem and a therapeutic dilemma].
    van Weering HG; Mijatovic V; Groot J; Hompes PG; Brölmann HA
    Ned Tijdschr Geneeskd; 2007 Mar; 151(13):725-9. PubMed ID: 17471770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in hospitalized women with pelvic inflammatory disease in Oslo over the past decade.
    Sørbye IK; Jerve F; Staff AC
    Acta Obstet Gynecol Scand; 2005 Mar; 84(3):290-6. PubMed ID: 15715539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroperitoneal fibrosis secondary to actinomycosis with no intrauterine device.
    Milam MR; Schultenover SJ; Crispens M; Parker L
    Obstet Gynecol; 2004 Nov; 104(5 Pt 2):1134-6. PubMed ID: 15516426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intrauterine device and pelvic inflammatory disease revisited: new results from the Women's Health Study.
    Lee NC; Rubin GL; Borucki R
    Obstet Gynecol; 1988 Jul; 72(1):1-6. PubMed ID: 3380496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of the patient with an intrauterine device and a unilateral adnexal mass.
    Hershey DW
    J Reprod Med; 1980 Aug; 25(2):75-8. PubMed ID: 7411528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.